组织激肽释放酶家族及其功能的研究进展
出处
《广西医学》
CAS
2006年第3期385-389,共5页
Guangxi Medical Journal
基金
国家自然科学基金资助项目(39960074)
参考文献22
-
1Diamandis EP,Yousef GM.Human tissue kallikreins:a family of new cancer biomarkers[J].Clin Chem,2002,48(8):1198 ~ 1205.
-
2Yousef GM,Diamandis EP.The new human tissue kallikrein gene family:structure,function,and association to disease[J].Endocr Rev,2001,22(2):184 ~ 204.
-
3Valdes G,Chacon C,Corthom J,et al.Tissue kallikrein in human placenta in early and late gestation[J].Endocrine,2001,14(2):197 ~ 204.
-
4Rehault S,Monget P,Mazerbourg S,et al.Insulin-like growth factor binding proteins (IGFBPs) as potential physiological substrates for human kallikreins hK2 and hK3[J].Eur J Biochem,2001,268(10):2 960 ~ 2 968.
-
5Balbay MD,Juang P,llansa N,et al.Stable transfection of human prostate cancer cell line PC-3 with prostate specific antigen induces apoptosis both in-vivo and in-vitro[J].Proc Am Assoc Cancer Res,1999,40:225 ~ 226.
-
6Diamandis EP.Prostate-specific antigen:a cancer fighter and a valuable messenger? [J].Clin Chem,2000,46(7):896~900.
-
7Borgono CA,Michael IP,Diamandis EP.Human tissue kallikreins:physiologic roles and applications in cancer[J].Mol Cancer Res,2004,2(5):257~280.
-
8Petraki CD,Karavana VN,Revelos KI,et al.Immunohistochemical localization of human kallikreins 6 and 10 in pancreatic islets[J].Histochem J,2002,34(6-7):313 ~ 322.
-
9Simon M,Jonca N,Guerrin M,et al.Refined characterization of corneodesmosin proteolysis during terminal differentation of human epidermis and its relationship to desquamation [J].J Biol Chem,2001,276 (23):20292~20299.
-
10Caubet C,Jonca N,Brattsand M,et al.Degradation of corneodesmosome proteins by two serine proteases of the kallikrein family,SCTE/KLK5/hK5 and SCCE/KLK7/hK7[J].J Invest Dermatol,2004,122(5):1 235 ~1244.
-
1冯忠,汪立松,王希佳.组织激肽释放酶与缺血性脑卒中患者预后的相关性研究[J].放射免疫学杂志,2013,26(5):618-620.
-
2汪宁卿,邹金,刁勇.质粒介导的组织激肽释放酶结合蛋白在肺癌相关细胞内的表达及其生物学活性研究[J].药学学报,2013,48(3):359-365. 被引量:5
-
3姜春华,曹郁生.组织激肽释放酶的研究进展[J].中国生物制品学杂志,2006,19(3):326-327. 被引量:3
-
4刘蔚,孙黎光,池北雅彦.ELISA法测定人血液中组织激肽释放酶含量的研究[J].中国医科大学学报,1995,24(5):448-450. 被引量:1
-
5张琴,冉晓,汪道文.血管紧张素转化酶抑制剂能提高冠心病患者血浆中人组织激肽释放酶的含量[J].中国分子心脏病学杂志,2010,10(2):102-105. 被引量:4
-
6宣强,莫曾南.组织激肽释放酶基因7研究进展[J].广西医科大学学报,2006,23(6):1034-1036.
-
7曹步清,刘铁牛.组织激肽释放酶-激肽系统及其与心血管疾病的关系[J].检验医学与临床,2012,9(21):2731-2733. 被引量:6
-
8黄方,胡斌,石瑞峰,张仁良.组织激肽释放酶预防大脑中动脉支架术后支架内再狭窄[J].中华神经科杂志,2017,50(4):244-244. 被引量:2
-
9洪宗元,张秀清,黄帼,凌代俊,徐希平.组织激肽释放酶基因多态性A1789G对高血压患者血浆肌酐水平的影响(英文)[J].中国临床药理学与治疗学,2005,10(6):637-641. 被引量:1
-
10秦又发,田海红,孙飞,秦旭平.氯沙坦对两肾一夹高血压大鼠肾脏的保护作用及PRCP-激肽释放酶调节轴的影响[J].药学学报,2013,48(1):59-65. 被引量:4